Medical Center, professional approach

CYTOTRON is a huge machine,used in RFQMR procedure which looks like a modern whole body MRI scanner but has a bigger bore. The bore has a gantry, that carries about 288 guns. Each of the guns produces high instantaneous magnetic field and radio frequency, it also consist of a special near field antenna and parabolic reflectors to deliver these signals. These guns emit packets or Quantum of programmed signals in time and space that are focused to the target of interest using laser guides. These emitted string of packets, which contain the dosimetry required for a specific medical condition is delivered by the antenna. The beams are then rotated in 360 degrees around the target.

The patient is made to lie down on a traveling bed, the bed travels into the bore of the CYTOTRON, the laser guides come on and the technician focuses the guns as per a pre-prepared template. The secondary dosimetry that is prepared by a trained Doctor is initiated from the control room, and the CYTOTRON starts it’s job. After completing the assigned dose of radiation, the device automatically stops. The patient is then removed out of the bore.

Injury is common in our body, due to various reasons like disease, accident, chemical pollution, stress and mechanical wear and tear. Regeneration is as common as injury. Regeneration is a repair process that is initiated by the injury itself, injured cells of our body signal out like an SOS in a sinking ship. These signals, to put it in simple terms, consist of information that contains the nature of injury (bacteria, virus or trauma), location of the injury, intensity of damage and specific time available for repair. The body’s immune system is the first to arrive, pain signals are transmitted to inform the macroscopic body of the injury, and inflammation cordons the area to prevent further damage. Repair means to replace the destroyed cells with new ones in a very controlled manner, that no unlawful elements enter the newly formed society and corrupt it. Now the cells look into the rule book (DNA) and find out a solution for the problem in hand, the rule book also specifies who is going to head the commission (type of protein), the commissioner then needs a job allocation protocol (protein synthesis), to conduct it’s duties. The commissioner will also need vehicles (enzymes), stationary (minerals), fuel (cell energy or ATP) and protection (white blood cells or WBC). The commissioner then waits for the final order that should arrive, to say all is well and ready to start. These orders arrive through a special channel, called trans-membrane potential pathway (TMP pathway), once arrived the work is completed within specified time if all resources are available. What happens after all the preparations are done and the final orders don’t arrive because the specific pathway is non functional or on tool-down strike? Like what happens in most commissions, all files pertaining to the repair job will be "Marked Pending" till somebody clears the mess at the pathway and delivers the "final order".

Tranmembrane potential pathway is a function of the difference in the voltage between the inside and outside of cells and governed by precise pumping of negative and positive ions between the inside and outside of the cells. This is an extremely accurate and highly programmed operation and needs tremendous amount of energy. If there are any mismatches in this operation, the pathways get shut and many cellular functions get effected and are the major cause of all non-communicable diseases.

This is where RFQMR comes into play, to take over this operation, regularize the functions of Tranmembrane pathways and successfully deliver the "final order" to the commission to continue the repair job.

Theoretically Yes!, but practically there are many issues, first of all, not much is understood about protein synthesis and TMP pathways. In areas it is understood, it is a long drawn process to create precise algorithms and delivery systems, simulate the outcome and then conduct clinical trials before it can be used to cure diseases. To tell an example, it took more than 15 years to treat the first patient for osteoarthritis, similarly for Cancer. Researchers have to get to the basics, apply their minds, understand the process, the protein involved, it’s structure right up to it’s atomic structure and bonding. Though it is a time consuming process, it is worth the trouble, one lifetime may not be enough.

Dosimetry means the process of preparing the dose of various parameters for different indications of use. In RFQMR, there is a primary dosimetry and a secondary dosimetry. Primary dosimetry is an extremely complex process that is done by the researcher; it needs expensive laboratory with advanced tools and resources. Primary dosimetry determines the various parameters required, like modulation characteristics like wave front frequencies, the harmonics, the spin parameters, rotational timings, tissue characteristics like proton density, radio behavior, depth of penetration required etc,. It is the primary dosimetry that determines, pathway signaling for a specific protein believed to be performing certain function that you need to correct.

Primary dosimetry is fixed at the time of manufacturing the CYTOTRON machine. This cannot be changed or altered by any user, as there are locks and interlocks to prevent manipulation of the primary dosimetry. The secondary dosimetry is that part of the dosimetry that needs external inputs that is specific to the patient being treated like certain dimensions of the anatomy of the patients in the fixed proton density dosimetry or gun fire path details in variable proton density dosimetry used in case of treating Cancer. The user can only provide the required inputs from the patient, and the final delivery is automatically controlled by the CYTOTRON.

Proton Density or PD is one of the most important parameter required for RFQMR dosimetry. Basically, it is the density of hydrogen atoms that is found in a given tissue type. Proton densities of all normal tissues in the body are known. So any secondary dosimetry is done to apply on a known tissue type is call "fixed proton density dosimetry". However, in case of Cancer tissues, the dosimetry is different from that of a known normal tissue, that means two Cancer tissues in two parts of the body of the same patient will be different; hence the CYTOTRON needs to know the proton density of the tumor tissue as well as all the tissues surrounding the Cancer. The CYTOTRON also needs to know the proton density of all the tissue types that comes in the firing lines of the RFQMR guns. This type of dosimetry is called "variable proton density dosimetry".

All Radiations are classified under the Electromagnetic Spectrum. This includes, visible light, gama rays, x-rays and radio frequency radiations etc. Yes all forms of radiations are harmful, some are more and some are less. The energy delivered by any radiation is proportional to its frequency and power. Frequencies in the higher EM spectrum are extremely harmful as they cause ionization of biological structure. This includes x-rays, gamma rays and the radiations used in radiation therapy for treating cancer. The microwaves used in your kitchen falls under mid-spectrum and they produce heat in the biological tissues. The lower end of the spectrum neither produce heat nor ionize the tissue. The lower end of the spectrum can be used to carry enormous amount of information and minute changes, when compared to high end or mid spectrum. Radiations in the lower end of the spectrum are not harmful in the sense like the higher end of the spectrum, where the ionising radiations can kill biological tissues. Low-end spectrum frequencies can cause minor physiological effects like depression or pain or some metabolic abnormalities, if uncontrolled.

In the modern world, we all live in an environment filled with all kinds of "Electromagnetic field", these fields are all around us, they pass through us, but neither they do any serious harm nor do they have any beneficial effects on biological tissue. Any source that produces electromagnetic energy has a field around it. Electromagnetic radiation or RF radiation, on the other hand is different, where radio frequency is radiated using an antenna system, for use by a precise recipient, like how the TV station radiates the RF waves for use by a TV receiver. Both transmitting and receiving device has to be in resonance with each other for the receiver to reproduce what is transmitted. CYTOTRON works as a RF transmitter, it contains special near field antennae, that delivers this radiation precisely to the target (tissue), which is in resonance with the transmitter (Cytotron).

First of all, the word "Alternative", is a very relative term and depends on the situation, for example, a patient who has considered to go for a knee replacement surgery, CYTOTRON may become an alternative treatment, while a patient who has chosen to take CYTOTRON treatment, knee replacement may be an alternative.… So it is a very wrong and misleading terminology, there is nothing called "main therapy" or "alternative therapy" in medicine originally, this is just concocted in recent times.

Secondly, I don’t have much knowledge about Magnetotherapy, though I have herd of. It must be something to do with magnets. CYTOTRON has nothing to do with this therapy; CYTOTRON is a specialised Magnetic Resonance Device that is designed for therapeutic purposes.

I too have heard of these machines from various sources, neither my organization nor me have got anything to do with it. CYTOTRON is a patented technology and is licensed only to one manufacturer "Scalene Cybernetics Limited" and is marketed only in one name "CYTOTRON", which is a registered trademark. Our organization follows international standards and is certified ISO 9001:2000, ISO 13485:2003 and other relevant standards and an organization of repute having a track record of more than 15 years.

I don’t know the intensions of these "look alikes" but it is always good to be careful before accepting to take any treatment from such places. Ask them for details, like the patients they have treated, their MRI scans before and after the treatment, reported by a qualified radiologist.The only thing I can say is, if in doubt, please report to us, we can clarify from our records if the machine you saw is a CYTOTRON that we would have supplied.

No. CYTOTRON for the treatment of Musculoskeletal Disorders and Terminal Cancer patients are not experimental. All required technical, safety and clinical requirements has been fulfilled and can be freely used for the treatment of patients falling under the above category. However, it is still experimental in treatment of Cancer as a primary therapy, or in combination with existing modalities. It is also experimental in the treatment of Neurological disorders and other non-communicable diseases.

Do you have different medicines for male/female or Blood group A or B etc., likewise, in CYTOTRON dosimetry or the protocol, there are no differences based on any of the above, mentioned in your question. I would further put it, CYTOTRON does not differentiate between population groups, race or religion. Remember CYTOTRON treatment is at cellular levels, where none of these matters.

Other than some contraindications, there are absolutely no restrictions. The contraindications are to stop certain group of drugs, that use the same or similar cellular pathways as CYTOTRON, like Calcium Channel Blockers, Proton pump inhibiters, NSAIDs and Alkaloids (also food containing alkaloids) for all regenerative treatments and stop only Calcium channel blockers and proton pump inhibitors for treatment of degenerative treatment like Cancer. CYTOTRON treatment is known to deplete all B- vitamins, so this is supplemented for all patients during the course of treatment.

None of the implants are a contraindication as long as they are MRCompatible, that is, you are permitted to take an MRI scan by your radiologist. Pacemakers are absolutely contraindicated, even if it is MRCompatible. Pacemakers or any other radiosensitive implanted devices should not be allowed within 15 meters of the CYTOTRON machine.

I did not say CYTOTRON causes these effects; I said that low-end spectrum frequencies can cause these effects if "uncontrolled". The signals produced by CYTOTRON are precisely controlled, ten on board microprocessors and a powerful industrial computer in the CYTOTRON does this job for you. Uncontrolled low-end spectrum frequencies can cause a lot of trouble; this is why I said earlier that one should be careful about look alike machines or so called "special dosimetry and protocols". There are no adverse side effects reported in the proper use of CYTOTRON.

This question has come to me many times, from patients and the profession. As I told earlier, the user of CYTOTRON has no control over the primary dosimetry. The user can only use the secondary dosimetry to provide certain inputs relating to the anatomy of the patients. There is nothing to change here, the only change possible is that, the user may expose the patient for a longer time then recommended for commercial benefits this is unethical, and this can be dangerous to the patients for obvious reasons. In extreme situations, some unscrupulous user of CYTOTRON may manipulate with the protocol, to make the treatment look different from that of others who use CYTOTRON, just for commercial gains, and not to the benefit of the patients. The objective outcome (or effect as you call it) of CYTOTRON treatment can only be established by comparing the MRI scans taken before and three months after the treatment, where the post treatment MRI scan should show significant increase in cartilage thickness when compared to the MRI scan before the treatment.

First of all, it depends on what you mean by "success rate". Success can be viewed from both subjective side and objective side. Subjective side is how the patient feels and his general quality of life after the treatment and the objective side (more important for science guys like me) is the actual physical measurements that determine the end point of our research. In the studies done on osteoarthritis, the subjective success is about 85% and the objective success is about 98%; this means 85% of the 202 patients treated during the phase II clinical trials, could be pain free, increased movement of their treated joints and could walk longer distance than what they could before the treatment, climb stairs and drive, while 98% of the treated patient had significant growth in their cartilage tissue as proven by the MRI scans three months after treatment. If I look at from the patient point of view, I would say the success rate is 85%, as these patients have achieved what they wanted. If I look from the research project side, the success rate is 98%, as we could achieve our end-point in 98% of the patients treated.